TECTONIC THERAPEUTIC, INC. Total Shareholder Rtn Amt
TECTONIC THERAPEUTIC, INC. (TECX) reported Total Shareholder Rtn Amt of $243.84 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-24.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-04-24
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $243.84 DEF 14A · filed 2026-04-24 |
| 2024-12-31 | $539.70 DEF 14A · filed 2026-04-24 |
| 2023-12-31 | $190.77 DEF 14A · filed 2026-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |